Rxivist logo

miR-200c Suppresses Stemness And Increases Cellular Sensitivity To Trastuzumab In HER2+ Breast Cancer

By Cailu Song, Jin Wang, Hua Wang, Peng Liu, Longzhong Liu, Lu Yang, Hailin Tang, Xiaoming Xie

Posted 25 Apr 2017
bioRxiv DOI: 10.1101/130682

Resistance to trastuzumab remains a major obstacle in HER2-overexpressing breast cancer treatment. miR-200c is important for many functions in cancer stem cells (CSCs), including tumor recurrence, metastasis and resistance. We hypothesized that miR-200c contributes to trastuzumab resistance and stemness maintenance in HER2-overexpressing breast cancer. In this study, we used HER2-positive SKBR3, HER2-negative MCF-7, and their CD44+CD24- phenotype mammospheres SKBR3-S and MCF-7-S to verify. Our results demonstrated that miR-200c was weakly expressed in breast cancer cell lines and cell line stem cells. Overexpression of miR-200c resulted in a significant reduction in the number of tumor spheres formed and the population of CD44+CD24- phenotype mammospheres in SKBR3-S. Combining miR-200c with trastuzumab can significantly reduce proliferation and increase apoptosis of SKBR3 and SKBR3-S. Overexpression of miR-200c also eliminated its downstream target genes. These genes were highly expressed and positively related in breast cancer patients. Overexpression of miR-200c also improved the malignant progression of SKBR3-S and SKBR3 in vivo. miR-200c plays an important role in the maintenance of the CSC-like phenotype and increases drug sensitivity to trastuzumab in HER2+ cells and stem cells.

Download data

  • Downloaded 357 times
  • Download rankings, all-time:
    • Site-wide: 93,063
    • In cancer biology: 2,767
  • Year to date:
    • Site-wide: 150,057
  • Since beginning of last month:
    • Site-wide: 134,709

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide